Skip to main content
. 2019 Oct 1;18(6):5853–5858. doi: 10.3892/ol.2019.10943

Table II.

Comparison of general clinical data between the two groups (mean ± SD) [n (%)].

Clinical factors Control group (n=80) Observation group (n=78) t/χ2 value P-value
BMI (kg/m2) 23.98±1.26 24.36±1.57 1.68 0.095
Heart rate (times/points) 105.61±11.53 105.79±11.66 0.098 0.922
Urea nitrogen (mmol/l) 12.97±3.51 13.16±3.71 0.331 0.741
Age 49.67±5.68 50.45±4.71 0.938 0.35
Tumor staging 0.239 0.625
  I+II 39 (48.75) 35 (44.87)
  IIIa+IIIb 41 (51.25) 43 (55.13)
Borrmann classification 0.534 0.465
  I+II 37 (46.25) 32 (41.03)
  III+IV 43 (53.75) 46 (58.97)
Sex 0.143 0.378
  Male 45 (56.25) 42 (53.85)
  Female 35 (43.75) 36 (46.15)
Drinking history 0.38 0.617
  Yes 51 (63.75) 47 (60.26)
  No 29 (36.25) 31 (39.74)
Degree of differentiation 0.355 0.837
  Differentiated type 21 (26.25) 21 (26.92)
  Poorly differentiated 32 (40) 34 (43.59)
  Undifferentiated type 27 (33 75) 23 (29.49)
Lymph node metastasis 0.894 0.345
  Yes 46 (57.5) 39 (50)
  No 34 (42.5) 39 (50)
Degree of differentiation 0.261 0.61
  High school and below 11 (13.75) 13 (16.67)
  Over Senior High School 69 (86.25) 65 (83.33)
History of smoking 0.23 0.632
  No 41 (51.25) 37 (47.44)
  Yes 39 (48.75) 41 (52.56)